New Zealand markets close in 6 hours 41 minutes

Hepion Pharmaceuticals, Inc. (336.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
1.27000.0000 (0.00%)
At close: 08:01AM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 6.12M
Enterprise value -4.18M
Trailing P/E 0.38
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.30
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.09

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-88.45%
S&P500 52-week change 323.99%
52-week high 311.5200
52-week low 31.0800
50-day moving average 31.6694
200-day moving average 32.9742

Share statistics

Avg vol (3-month) 3232
Avg vol (10-day) 3650
Shares outstanding 55.47M
Implied shares outstanding 65.58M
Float 85.02M
% held by insiders 10.31%
% held by institutions 113.02%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 311 May 2023

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-71.07%
Return on equity (ttm)-172.45%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -37.15M
Net income avi to common (ttm)-38.52M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)13.11M
Total cash per share (mrq)2.39
Total debt (mrq)175.27k
Total debt/equity (mrq)2.33%
Current ratio (mrq)5.99
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-36.29M
Levered free cash flow (ttm)-27.67M